MarketPulse

ADHD treatment

2 articles
BenzingaBenzinga··Benzinga

Collegium Completes $650M AZSTARYS Acquisition, Raises 2026 Guidance

Collegium Pharmaceutical acquired ADHD treatment AZSTARYS from Corium for $650M, immediately boosting profitability with patent protection through 2037.
COLLacquisitionrevenue growth
The Motley FoolThe Motley Fool··Seena Hassouna

Collegium's ADHD Pivot Accelerates as General Counsel Trims Stakes

Collegium's General Counsel sells modest stake as company bets $650M acquiring AZSTARYS to accelerate ADHD strategy shift, with Jornay PM showing 48% growth.
COLLrevenue growthinsider sale